Featured Research

from universities, journals, and other organizations

Yale Researchers Develop Promising AIDS Vaccine

Date:
October 16, 2001
Source:
Yale University
Summary:
Yale researchers have developed an AIDS vaccine that has proved effective in animal studies and holds promise for humans.

Yale researchers have developed an AIDS vaccine that has proved effective in animal studies and holds promise for humans.

"Based on our results, we think it is likely that this vaccine could be an effective AIDS vaccine in humans," said principal investigator John K. Rose, professor of pathology and cell biology at Yale University School of Medicine.

For the past six years, Rose and his team have been developing a common livestock virus as a vaccine vector (a vaccine delivery system). This vector system, which is called VSV (vesicular stomatitis virus), was highly effective in animal models for influenza and measles. Published in the September 7 issue of Cell, the results of two new studies show that vaccination with the VSV vector encoding AIDS virus proteins can protect monkeys from AIDS caused by a virus that is a hybrid between a human AIDS virus and a monkey AIDS virus.

The research team first vaccinated seven monkeys with their new vaccine and then infected them with the AIDS virus. Eight control monkeys were also infected with the AIDS virus, but did not receive the vaccine. "We found that seven out of eight unvaccinated monkeys developed AIDS in an average of five months, while vaccinated monkeys have been AIDS-free for up to 14 months," said Rose.

Rose said that two other studies using DNA vaccine approaches published in Science in the past year demonstrated similar protection, but that those DNA vaccine vectors may not be as practical as VSV.

"An advantage of the VSV vector system over the others is that it does not require multiple injections and instead can be given as nasal drops," said Rose. "In the developing world and areas that have been hit hard with HIV and AIDS, it would be impractical and very expensive to inject millions of people with DNA vaccines. The VSV-based vaccine would be a cost-effective and equally successful alternative to the other vaccines that have been tested. We are truly excited about this advance."

Rose said the next step is to begin preparing for a Phase I safety trial in humans. He will present the current findings at the AIDS Vaccine 2001 Conference in Philadelphia on September 6.

Other authors on the study include first author Nina F. Rose, Linda Buonocore and Anjeanette Roberts of Yale; Preston A. Marx of the Aaron Diamond AIDS Research Center and Tulane University; Amara Luckay of the Aaron Diamond AIDS Research Center; Douglas F. Nixon, Walter J. Moretto and Sean M. Donahoe of the Gladstone Institute of Virology and Immunology and David Montefiori of Duke University.


Story Source:

The above story is based on materials provided by Yale University. Note: Materials may be edited for content and length.


Cite This Page:

Yale University. "Yale Researchers Develop Promising AIDS Vaccine." ScienceDaily. ScienceDaily, 16 October 2001. <www.sciencedaily.com/releases/2001/10/011016070122.htm>.
Yale University. (2001, October 16). Yale Researchers Develop Promising AIDS Vaccine. ScienceDaily. Retrieved September 22, 2014 from www.sciencedaily.com/releases/2001/10/011016070122.htm
Yale University. "Yale Researchers Develop Promising AIDS Vaccine." ScienceDaily. www.sciencedaily.com/releases/2001/10/011016070122.htm (accessed September 22, 2014).

Share This



More Health & Medicine News

Monday, September 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com
Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins